Shares of DIAGNOS Inc. (CVE:ADK – Get Free Report) dropped 3.6% on Tuesday . The company traded as low as C$0.25 and last traded at C$0.27. Approximately 158,300 shares were traded during mid-day trading, an increase of 71% from the average daily volume of 92,336 shares. The stock had previously closed at C$0.28.
DIAGNOS Stock Down 3.6 %
The company has a debt-to-equity ratio of 245.28, a current ratio of 0.39 and a quick ratio of 0.68. The stock has a market capitalization of C$21.58 million, a PE ratio of -6.63 and a beta of -0.44. The company has a 50 day moving average price of C$0.34 and a 200-day moving average price of C$0.33.
DIAGNOS (CVE:ADK – Get Free Report) last issued its quarterly earnings data on Wednesday, August 21st. The company reported C($0.01) EPS for the quarter, topping the consensus estimate of C($0.02) by C$0.01. The company had revenue of C$0.04 million during the quarter, compared to the consensus estimate of C$0.07 million. As a group, analysts forecast that DIAGNOS Inc. will post -0.02 earnings per share for the current fiscal year.
About DIAGNOS
DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes.
Read More
- Five stocks we like better than DIAGNOS
- How to Choose Top Rated Stocks
- Super Micro Computer Soars 28%: Is It Really Out of the Woods?
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Traders Are Flocking Back to Oil: What’s Fueling the Optimism
- What is Put Option Volume?
- 3 Hot Stock Trends to Ride Into 2025
Receive News & Ratings for DIAGNOS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DIAGNOS and related companies with MarketBeat.com's FREE daily email newsletter.